IMMP vs KZIA
Immutep Ltd. and Kazia Therapeutics Ltd., side by side — 8 fiscal years reported in AUD, drawn from SEC filings.
Most recent reported year
| Metric | IMMP | KZIA |
|---|---|---|
| Revenue | AUD 10.3M | AUD 42,000 |
| Net income | AUD -61.4M | AUD -20.7M |
| Gross margin | · | · |
| Net margin | −594.6% | · |
| Return on equity | −36.9% | · |
| Diluted EPS | −AUD 0.04 | −AUD 0.04 |
| Dividend / share | · | · |
| Payout ratio | −0.0% | · |
| Free cash flow | AUD -62.1M | · |
| Equity | AUD 143.6M | AUD -8.3M |
| Net debt / equity | · | · |
| Current ratio | 11.69× | 0.35× |
| Revenue CAGR 5y | −8.9% | · |
| Profit CAGR 5y | · | · |
IMMP bills 246.0× the revenue of KZIA, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
8 years side by side
| Fiscal year | IMMP | KZIA |
|---|---|---|
| FY2024 | AUD 10.3M | AUD 42,000 |
| FY2023 | AUD 7.8M | AUD 2.3M |
| FY2022 | AUD 5.2M | AUD 0 |
| FY2021 | AUD 6.8M | AUD 0 |
| FY2020 | AUD 4.0M | AUD 15.2M |
| FY2017 | AUD 7.4M | AUD 119,000 |
| FY2016 | AUD 4.2M | AUD 249,000 |
| FY2015 | AUD 2.0M | AUD 406,000 |
Bottom line
| Fiscal year | IMMP | KZIA |
|---|---|---|
| FY2024 | AUD -61.4M | AUD -20.7M |
| FY2023 | AUD -42.7M | AUD -26.8M |
| FY2022 | AUD -39.9M | AUD -20.5M |
| FY2021 | AUD -32.2M | AUD -25.0M |
| FY2020 | AUD -29.9M | AUD -8.4M |
| FY2017 | AUD -12.7M | AUD -6.0M |
| FY2016 | AUD -9.4M | AUD -10.7M |
| FY2015 | AUD -62.0M | AUD -12.1M |
8 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2024 | +AUD 10,289,373 | IMMP |
| FY2023 | +AUD 5,530,625 | IMMP |
| FY2022 | +AUD 5,200,128 | IMMP |
| FY2021 | +AUD 6,758,073 | IMMP |
| FY2020 | −AUD 11,214,867 | KZIA |
| FY2017 | +AUD 7,234,307 | IMMP |
| FY2016 | +AUD 3,972,534 | IMMP |
| FY2015 | +AUD 1,622,921 | IMMP |
The higher-revenue side has changed between IMMP and KZIA over this period. The gap has widened since the earliest year compared.
8 of 10 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
IMMP's return on equity has been more volatile than KZIA's over the 8 comparable fiscal years — 44.5 percentage points of standard deviation against 35.7.
8 of 10 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between IMMP and KZIA over these 8 fiscal years — IMMP led in 4 and KZIA in 4.
8 of 10 comparable fiscal years — a year missing data on either side is not counted.